False Claims Act suit alleging that medical practices engaged in a scheme to overbill Medicare for Amgen Inc. drugs is now dismissed, a New York federal district court said.
Azon Medical agreed to pay $1 million to resolve liability under the False Claims Act for alleged improper billing of P-Stim neurostimulators, the U.S. Attorney ...
Some results have been hidden because they may be inaccessible to you